Best medication for restless legs
This page primarily discusses long-term treatments for RLS. For treatments of the acute "creepy", "crawly", "aching" feelings in the legs visit the "Getting relief" page where nonpharmacological therapies are discussed.
RLS can be treated. The goals of treatment are to:
-
Prevent or relieve symptoms.
-
Increase the amount of sleep you're getting and improve the quality of your sleep.
-
Treat or correct any underlying condition that may trigger or worsen RLS.
No single medicine works for all people who have RLS. It may take several changes in medicines and dosages to find the best approach. Sometimes, a medicine will work for a while and then stop working.
Iron supplementation for RLS
Before prescribing specific Restless Legs Syndrome (RLS) medications, a physician will typically test ferritin levels (iron stores). Even if a person is not clinically anemic, low to normal iron levels can trigger RLS symptoms in the brain. If your ferritin is below 75µg/L, iron supplementation (oral or IV) may resolve the RLS symptoms without the need for lifelong medication. Oral Iron is often prescribed with Vitamin C (100–200mg vitamin C) to increase absorption. Intravenous (IV) Iron is used if oral iron is not tolerated or if ferritin levels remain low despite oral supplementation. A common oral iron regime is 325mg ferrous sulfate (65mg elemental iron).
Other supplements including magnesium, vitamin B12, vitamin D and vitamin C may have a role in RLS. These are discussed in the "Vitamins" page.
Are Alpha-2-delta ligands (Gabapentinoids) the best for RLS?
Alpha-2-delta ligands as a class of medication is now often considered the first-line treatment (recommended by American Academy of Sleep Medicine) for RLS because it helps with both the physical sensations of RLS and the sleep disturbances associated with the condition. Gabapentin, Gabapentin enacarbil and Lyrica are three alpha-2-delta ligands medications. See the "Medication" section from the Restless Legs Syndrome Foundation.
Gabapentin for RLS
Generic Gabapentin (Neurotonin)
Unlike dopamine agonists (e.g. Sifrol) that act like a "gas pedal" for the brain's reward system, Gabapentin functions more like a volume knob, reducing down the overactive sensory signals in the legs. If the RLS includes sensations that feel like burning, aching, or "electric shocks," Gabapentin is particularly effective because it was originally designed to treat nerve pain. One of the biggest perks of Gabapentin is its sedative effect. While Sifrol (see below) helps the urge to move, Gabapentin often helps you actually stay asleep once you get there.
Gabapentin is very closely related to pregabalin (see below). They are both gabapentinoids and both used to treat moderate to severe chronic RLS. While they work similarly by modulating calcium channels in the nervous system to "calm" overactive signals, gabapentin has a few unique quirks regarding how the body absorbs it. At a small 300mg dose, the body absorbs about 60% of the drug. If you step up to a 1,200mg dose, absorption plummets to roughly 35%. This causes unpredictable blood levels between different people.
Gabapentin is a good treatment alternative for RLS as it has:
-
Minimal augmentation: It carries a very low risk of making RLS symptoms worse over time, unlike older dopamine drugs.
-
Pain relief: It is particularly effective if the RLS is accompanied by "burning" or "tingling" sensations (neuropathic pain).
-
Cost: Generic gabapentin is generally very affordable, though the Enacarbil (Horizant) version can be more expensive.
Standard gabapentin (Neurontin) is not officially approved by the TGA in Australia or the FDA in the United States for RLS.
Gabapentin dosing
Because generic gabapentin features a strict absorption bottleneck in the gut, its dosing strategy for RLS is highly individualized requiring careful clinical titration to find the specific point where symptom relief is achieved without triggering daytime side effects. Standard protocols suggest starting with a very low dose (e.g., 100mg to 300mg) in the evening and slowly increasing it by 100mg to 300mg increments every few days until the "urge to move" subsides. For the majority of patients, the effective dose settles between 600mg and 900mg daily taken in the evening. In some cases with highly severe or refractory RLS doses may scale up to a maximum of 1,800mg to 2,400mg daily. The body's ability to absorb generic gabapentin drops sharply at these higher doses.
Immediate-release gabapentin reaches its peak level in the blood roughly 2 to 3 hours after ingestion and clears the system relatively fast. Therefore, timing must be aligned with an individual's specific symptom pattern. If symptoms only trigger when trying to fall asleep, the entire dose is taken roughly 2 hours before laying down. For patients whose legs begin to act up earlier in the day, such as during an evening commute or while sitting on the couch after dinner, the daily dose is split by taking a smaller dose (e.g., 300mg) around 4:00PM to 5:00PM, followed by the remaining maintenance dose (e.g., 600mg) right before bed.
Over-the-counter antacids containing aluminum or magnesium (like Mylanta) severely interfere with the absorption of generic gabapentin. The medication must be taken at least 2 hours apart from any antacid to ensure it actually enters the bloodstream.
Gabapentin side effects
-
Grogginess, heavy drowsiness (Somnolence): Can happen during the day if a large dose is taken before bed.
-
Fatigue: A general feeling of tiredness or low energy.
-
Unsteadiness: Mild dizziness or coordination issues affects roughly 15% to 20% of patients.
-
Cognitive effects: Occasional "word-finding" difficulties or mild forgetfulness.
-
Weight gain: increased appetite or fluid retention.
-
Kidney function: Gabapentin is cleared exclusively by the kidneys. If there is any reduction in kidney function gabapentin doses must be drastically lower to avoid toxic accumulation.
Gabapentin enacarbil (Horizant)
Gabapentin enacarbil is FDA-approved specifically for moderate-to-severe primary RLS. However it is not approved in Australia by the Therapeutic Goods Administration (TGA) for RLS. The tablets are engineered with a specialized extended-release matrix. Gabapentin enacarbil is designed to treat RLS with a longer duration of action. It is absorbed more consistently by the gut than generic gabapentin and stays in the bloodstream longer, providing more stable relief throughout the night.
Gabapentin enacarbil dosing
Unlike many neurological medications, patients start directly on the therapeutic 600mg dose without a step-up phase (provided kidney function is normal). The tablet is taken once daily with food. It must be taken with food. Taking it on an empty stomach drastically cuts how much of the medication your body absorbs, making it significantly less effective. Because it takes 5 to 8 hours to reach peak levels, taking it at 5:00PM ensures that the active drug slowly floods the nervous system right at bedtime maintaining a steady, flat ceiling of protection that keeps the legs quiet until sunrise. It has been shown that there is no added benefit to higher doses. No gradual tapering schedule is required when discontinuing the medication for RLS.
Note: The tablet must always be swallowed whole. Crushing, chewing, or splitting it destroys the extended-release mechanism, flooding the system with the drug all at once and risking severe side effects.
Potential Side Effects
Because Gabapentin enacarbil relaxes the central nervous system, the most common side effects are generally mild and clear up within a few weeks as the body adapts. Potential side effects include:
-
Sleepiness / Drowsiness (Somnolence): Somnolence Impacts up to 27% of patients. While this can actually help RLS patients fall asleep, the grogginess can sometimes spill over into the next morning. For about 70% of patients, this daytime sleepiness improves or resolves entirely within 3 to 4 weeks of continuous use.
-
Dizziness or a feeling of unsteadiness: Occurs in roughly 13% to 22% of patients. This is typically most noticeable when first starting the medication or if the dose is changed.
-
Mild fatigue: Affects about 7% of individuals.
-
Nausea: Occurring in approximately 7% of cases.
Pregabalin (Lyrica) for RLS
Pregabalin (Lyrica) has emerged as a cornerstone first-line medication in the management of RLS. In fact, as of the updated 2025 clinical guidelines, it, along with other gabapentinoids, is now widely considered the first-line pharmacological treatment for moderate to severe RLS, replacing older dopamine-based therapies (e.g. Sifrol) for many patients. Pregabalin is not officially approved by the Therapeutic Goods Administration (TGA) in Australia or by the FDA in the United States for RLS.
Pregabalin mode of action is that it binds to specific subunits of voltage-gated calcium channels in the central nervous system. By blocking these channels, it reduces the release of excitatory neurotransmitters (the chemical messengers that tell your nerves to fire). For RLS, this action dampens the uncomfortable, creeping, or pulling sensations in your legs and reduces the irresistible urge to move them.
Advantages of Pregabalin include:
-
No Augmentation: It carries a very low risk of making RLS symptoms worse over time, unlike older dopamine drugs.
-
Predictable and Efficient Absorption: Unlike its close relative, gabapentin, pregabalin is absorbed very rapidly and completely by the body. The amount that gets into the system relates predictably with the dose given, making it easier for a doctor to fine-tune dosages.
-
Dual Benefits for Sleep and Mood: Because it relaxes the central nervous system, pregabalin is highly effective at improving sleep quality and duration. It is also independently used to treat anxiety and nerve pain, making it an excellent "two-in-one" option if your RLS is accompanied by bedtime anxiety or neuropathy.
-
Increase Deep Sleep: Unlike many sleep aids, pregabalin increases "slow-wave sleep" (the deep, restorative phase of sleep), helping with the daytime fatigue often caused by RLS.
-
Physical Sensations and Periodic Limb Movement Syndrome: Pregabalin addresses both the physical "creepy-crawly" sensations and the Periodic Limb Movements (PLMs) that occur during sleep in some patients with RLS.
Pregabalin dosing
For RLS, pregabalin is typically prescribed as a once-daily oral dose taken 1 to 3 hours before bedtime, allowing it to peak just as symptoms usually start to flare up. Dosage usually starts low (e.g., 25mg to 75mg) and is gradually increased every 3 to 7 days until symptoms are gone or significantly reduced. For most people, the effective maintenance dose is between 150mg and 300mg per day.
Pregabalin side effects
-
Somnolence (Sleepiness/Grogginess): Heavy drowsiness is very common. While beneficial for getting to sleep despite RLS, it can cause significant "hangover" grogginess the next morning.
-
Unsteadiness, Mild Dizziness or Coordination Issues: This is the most frequently reported side effect, affecting roughly 20% to 30% of patients. It can cause a spinning sensation (vertigo) or a feeling of unsteadiness, especially when getting out of bed.
-
Cognitive Effects: Occasional "word-finding" difficulties or mild forgetfulness.
-
Weight Gain, Increased Appetite and Fluid Retention: Pregabalin is notably more associated with weight gain than either standard gabapentin or gabapentin enacarbil. It can cause a noticeable increase in appetite, and fluid retention can compound the weight change.
-
Dry Mouth
-
Blurred Vision: Temporary difficulty focusing the eyes or minor visual changes.
Are Dopaminergic agonists good for restless legs?
Historically, dopamine agonists (like Sifrol, ropinirole, or the rotigotine patch) were the absolute first-line choice for Restless Legs Syndrome (RLS). However, due to the risk of long-term augmentation (where the drug makes the RLS worse), modern medical guidelines, including those from the American Academy of Neurology and the International Restless Legs Syndrome Study Group, have shifted significantly. Currently, Alpha-2-delta ligands (gabapentin enacarbil, standard gabapentin, and pregabalin) are preferred as the first-line treatment for most patients. Even with this shift, there are still specific clinical scenarios where a doctor will choose a dopamine agonist over an alpha-2-delta ligand in the treatment of RLS. Reasons for using a dopamine agonist include:
Depression and Anxiety
Alpha-2-delta ligands carry a specific warning regarding the potential to trigger or worsen depression, mood instability, and suicidal ideation. If an RLS patient has a history of severe treatment-resistant depression, a doctor may prefer a dopamine agonist to avoid worsening mental health.
Falls Risk / Unsteadiness
Alpha-2-delta ligands commonly cause dizziness, unsteadiness, and mild coordination issues (ataxia). For frail elderly patients, or individuals who already have compromised balance or a high risk of dangerous falls, a low-dose dopamine agonist might be viewed as a safer alternative to protect physical mobility.
Severe Lung Disease or Sleep Apnoea
Because alpha-2-delta ligands act as central nervous system depressants, they carry a risk of slowing down breathing (respiratory depression). If a patient suffers from severe Chronic Obstructive Pulmonary Disease (COPD), severe untreated sleep apnea, or other advanced respiratory vulnerabilities, dopamine agonists are generally preferred because they do not suppress the respiratory drive.
Prior History of Severe Weight Gain or Lower Leg Edema
Significant weight gain and prominent lower-leg swelling (peripheral edema) are classic, bothersome side effects of long-term alpha-2-delta ligand use (especially pregabalin and standard gabapentin). For a patient who is already struggling with severe obesity, severe congestive heart failure, or chronic venous insufficiency, a dopamine agonist may be selected to prevent worsening fluid retention.
Failure or Intolerance to Alpha-2-Delta Ligands
Medicine is highly individualized. If a patient trial of gabapentin enacarbil or pregabalin fails to control their RLS symptoms at maximum tolerated doses, or if the resulting "brain fog" and daytime drowsiness are too severe to function at work, a dopamine agonist is the logical next step.
How effective is Sifrol (Pramipexole) in RLS?
Sifrol was first officially approved in 2006 by the FDA (USA), TGA (Australia) and the EMA (Europe) as a treatment for Restless Leg Syndrome (RLS). Although it had been used off label by some clinicians prior to that. Sifrol was once the first-line treatment for RLS however now, due to sifrol side effects, alpha-2-delta ligands (see above) are first-line treatments.
Sifrol is a common prescription medication used to manage RLS. Sifrol is a dopamine agonist. It works by binding to dopamine receptors (specifically the D2 and D3 receptor subtypes) in the basal ganglia (specifically the striatum), in the limbic system and the Diencephalospinal Pathway (Midbrain to Spinal Cord). Sifrol tricks the brain into thinking there is plenty of dopamine available restoring steady, stable signaling. Sifrol calms the brain sending signals that help regulate smooth, controlled muscle movements soothing those frantic, uncomfortable urges in the legs.
Sifrol is cleared almost entirely by the kidneys requiring careful dosing if kidney function is reduced.
Sifrol dosing
The typical starting dose is 0.125mg and can incremented up to a maximum of 0.75mg. It is typically taken in a low dose once daily, about 2 to 3 hours before bedtime, or whenever symptoms usually begin to appear. While Sifrol is prescribed in much higher doses for conditions like Parkinson's disease (up to 4.5 mg per day), the absolute maximum dose for RLS is strictly 0.75mg per day. Going over this limit heavily increases the risk of severe complications. Most people notice a significant reduction in symptoms within the first few days of treatment.
Sifrol side effects
When first starting Sifrol or increasing the dose for RLS, side effects are usually mild to moderate and often improve as your body adjusts. Side effects include:
-
Nausea and Dizziness: This is very common, affecting up to 15% to 20% of users initially. Taking the medication with a light snack can help minimize it.
-
Sleepiness: In some cases, users may experience "sleep attacks" or extreme drowsiness during the day.
-
Headache: Frequently reported during the first few weeks.
-
Dizziness or Lightheadedness: Sifrol can lower blood pressure slightly, especially when moving from a sitting or lying position to standing (orthostatic hypotension).
-
Insomnia or Vivid Dreams: Paradoxically, while it stops the leg twitching, it can occasionally disrupt your sleep architecture or give you wild, memorable dreams.
-
Impulse Control Issues: These are a rare but notable side effect of dopamine agonists. A change in behavior, such as increased gambling, shopping, hypersexuality, or binge eating have been noted due to the drug’s effect on the brain's reward system.
-
Augmentation: The most significant long-term concern with Sifrol is a phenomenon called augmentation. This occurs when the medication, over time, actually makes RLS symptoms worse. Signs of augmentation include: (i) symptoms starting earlier in the day (e.g., in the afternoon instead of the evening). (ii) The sensations spreading to other parts of the body, like the arms. (iii) The medication taking longer to kick in or requiring higher doses to achieve the same relief.
Note: Never stop taking Sifrol suddenly or change your dose on your own, as sudden withdrawal can trigger severe rebound symptoms and intense insomnia. Always collaborate with your prescribing doctor.
Does Ropinirole (Requip) treat restless legs?
Ropinirole belongs to the same class of medication as Sifrol being dopamine agonists. Ropinirole is primarily used to treat RLS and Parkinson’s disease. Just like Sifrol, it works by tricking the brain into thinking more dopamine is available. It binds primarily to D2 and D3 dopamine receptors in the basal ganglia and the diencephalospinal pathway, smoothing out movement control and quietening down the overactive sensory signals in the spinal cord that cause the classic "creepy-crawly", "urge to move" RLS sensations.
Ropinirole is approved by both the Therapeutic Goods Administration (TGA) in Australia and the FDA in the United States specifically for moderate-to-severe primary RLS.
Ropinirole is broken down by the liver (CYP1A2 enzyme). It can interact with other liver-processed drugs (like ciprofloxacin or smoking, which affects the enzyme).
Ropinirole dosing
For RLS, Ropinirole is typically taken once daily, roughly 1 to 3 hours before bedtime. Doctors usually start patients on a very low dose (0.25mg) and gradually increase it over several weeks to find the effective level while minimizing side effects. A dose of 2.0mg is the average effective dose found in most clinical trials.
If symptoms persist after 4 weeks of titration, and the medication is being well tolerated, a physician may continue to raise the daily dose by 0.5mg increments each week (e.g., 2.5mg in Week 5, 3.0mg in Week 6) up to a maximum recommended dose of 4.0mg once daily.
Ropinirole side effects
While effective, Ropinirole can cause several side effects, particularly when starting the medication or increasing the dose:
-
Nausea and Vomiting: Often the most common complaint; taking it with food can help.
-
Drowsiness/Sleepiness (Somnolence): While it helps you sleep through the night, daytime grogginess or fatigue can spill over into the next day. Some users experience "sleep attacks," where they fall asleep suddenly during the day.
-
Headache: Mild to moderate headaches are frequently reported during the initial titration phase (the period when your doctor slowly bumps up the dose).
-
Dizziness or Light-Headedness: Particularly when standing up quickly (orthostatic hypotension).
-
Augmentation: This is a paradoxical reaction where, over time, the RLS symptoms actually get worse. They may start earlier in the day, become more intense, or spread to other limbs (like the arms). If this happens, the dose usually needs to be lowered or the medication changed.
-
Impulse Control Disorders: Some patients experience intense urges to gamble, spend money, binge eat, increased sexual urges or engage in other repetitive behaviours.
When should I use Rotigotine (Neupro) for RLS
Rotigotine belongs to the same class of medication as Sifrol and Ropinirole being a dopamine agonist. Rotigotine is used to treat RLS, but it has a distinct delivery method that sets it apart from oral medications like Sifrol and Ropinirole. It is administered via a 24-hour transdermal (skin) patch rather than a pill. Rotigotine is often considered when:
-
A patient has difficulty swallowing pills.
-
RLS symptoms are present throughout the day, not just at night.
-
A patient experiences significant "rebound" symptoms as their evening dose of oral medication wears off.
Benefits of transdermal administration
Because Rotigotine is absorbed through the skin, it provides continuous 24-hour medication delivery. Unlike pills that cause "peaks and valleys" in blood concentration, the patch maintains a stable level of the drug in the system. This continuous delivery can be particularly helpful for patients who experience RLS symptoms during the day or very early in the morning (morning rebound).
Rotigotine dosing
The patch is applied once daily to clean, dry skin (usually on the abdomen, thigh, hip, or shoulder). It should be moved to a different spot every day to prevent skin irritation. You shouldn't use the same spot twice within 14 days.
Rotigotine side effects
Rotigotine shares the typical side effects of dopamine agonists, with one unique addition being application site reactions. Possible side effects are:
-
Application Site Reactions: This is the most common side effect. Redness, itching, or swelling can occur where the patch is placed.
-
Nausea: Similar to Ropinirole, though sometimes less intense due to the lack of "peaks" in drug levels.
-
Sleepiness, Drowsiness and General Tiredness (Somnolence): Are frequently reported, as the continuous 24-hour delivery means the dopamine pathways are continuously stimulated day and night.
-
Dizziness or Light-headedness: Potential dizziness when standing up quickly (orthostatic hypotension).
-
Augmentation: This is a paradoxical reaction where, over time, the RLS symptoms actually get worse. They may start earlier in the day, become more intense, or spread to other limbs (like the arms). If this happens, the dose usually needs to be lowered or the medication changed. While Rotigotine is a dopamine agonist, some studies suggest the risk of augmentation may be slightly lower (or delayed) compared to short-acting oral agonists because of the stable, continuous delivery. However, it is still a significant risk.
-
Impulse Control Disorders: Some patients experience intense urges to gamble, spend money, binge eat, increased sexual urges or engage in other repetitive behaviours.
Why are Opioids used in restless legs syndrome
Low potency opioids can be effective for intermittent RLS. The use of opioids is considered if there is:
-
Refractory RLS: Severe symptoms that fail to respond to standard first-line medications.
-
Dopamine Agonist Augmentation: When long-term use of dopamine drugs (like pramipexole or ropinirole) backfires, causing symptoms to become progressively worse, start earlier in the day, or spread to other body parts. Opioids are frequently used to help bridge patients off dopamine agonists.
-
Severe Painful Sensations: When RLS manifests with severe pain or deep aching that doesn't yield to nerve-pain medications.
Medical guidelines, including those from the American Academy of Sleep Medicine (AASM) and International Restless Legs Syndrome Study Group (IRLSSG) recommend:
-
Methadone: Commonly considered a gold standard for severe refractory RLS at very low doses (typically 2.5mg to 10mg daily). It has a long half-life, providing consistent cover through the night with a low rate of dose escalation.
-
Buprenorphine: Used in low-dose formulations (sublingual or transdermal). Its unique pharmacology provides strong efficacy with a lower risk of respiratory depression.
-
Oxycodone / Extended-Release Oxycodone-Naloxone: Low-dose, long-acting formulations have demonstrated strong clinical trial success in reducing RLS symptoms and improving sleep quality.
-
Codeine or Tramadol: Occasionally used for mild-to-moderate intermittent symptoms, though tramadol can sometimes trigger augmentation or interact with antidepressants.
A large percentage of patients with severe refractory RLS experience profound or complete symptom relief with the use of opioids. Opioids do not cause augmentation (where symptoms get progressively worse), which is why they are so valuable for severe RLS. Long-term clinical studies on low-dose opioids for RLS show that addiction rates and the need to constantly increase the dose are extremely low compared to chronic pain treatment, provided there is proper medical oversight.
Side effects of opioids
The side effects of opioids in RLS are usually minimal due to the low doses. However, potential side effects are nausea, vomiting, constipation, sedation, drowsiness, cognitive dysfunction, hallucination, mood disturbance, anxiety, myoclonus, cough reflex inhibition, dry mouth, bronchospasm, respiratory depression, worsening sleep apnoea, miosis, muscle rigidity and more.
What Benzodiazepines should I take for restless legs?
While benzodiazepines are not typically the first choice for treating RLS, doctors usually reserve them for specific, tailored situations. Benzodiazepines might be used in patients with intermittent symptoms, particularly in patients who suffer from sleep initiation insomnia. They may also be prescribed as an additional medication for an acute RLS flare up. Benzodiazepines work a bit differently than other RLS medications. Instead of stopping the uncomfortable leg sensations themselves, they primarily act as a sleep aid to help you sleep through the symptoms as well as reducing the number of nighttime awakenings caused by involuntary leg movements (PLMS). Benzodiazepines can help relax muscles and calm the anxiety or frustration that often builds up when trying to fall asleep with RLS.
While several Benzodiazepines exist, two are most frequently discussed for sleep and RLS:
-
Clonazepam (Klonopin): This is the most widely studied and prescribed benzodiazepine for RLS. It has a long half-life (it stays in the system for a long time), which helps keep you asleep throughout the night.
-
Temazepam (Restoril) / Alprazolam (Xanax): Sometimes used, though shorter-acting options are usually preferred if daytime grogginess is a major issue.
Side effects of benzodiazepines
Side effects include:
-
Daytime Somnolence (sleepiness): Because long-acting drugs like clonazepam stay in the system, feelings of being groggy, tired, or uncoordinated the next morning may be experienced.
-
Tolerance and Dependence: Over time, the body can get used to the medication, meaning a higher dose might be needed to get the same sleep benefits. They can also be habit-forming.
-
Sleep Apnoea Risk: Benzodiazepines relax the muscles in the throat, which can worsen sleep apnoea.
Do vibrating leg devices work for RLS?
Using a vibrating device placed on or behind the legs is an effective, drug-free way to find relief from RLS. Many patients find it acts as a "brakes" system for the intense, uncomfortable nighttime urges to move. When the legs are placed on a vibrating pad, the physical sensation of the vibration travels up the nerve pathways much faster than the slow, agonizing RLS sensations. This effectively "closes the gate" in the spinal cord, blocking the uncomfortable RLS signals from reaching the conscious brain. RLS symptoms are worst when blood flow naturally slows down at rest. Continuous vibrations stimulate the local blood vessels and muscle spindles, increasing localized blood flow and helping muscles relax.
On the internet there are a number of vibrating mats for RLS. A medically proven device is the Nidra device (TOMAC system). Rather than a flat pad, these are soft bands you wrap around your upper calves. They use specialized electrical pulses to activate the peroneal nerve, simulating the exact muscular relief of walking throughout the night without waking you up.
The Nidra is FDA-cleared and widely available in the United States. In Australia the Nidra device cannot be purchased over the counter. You must be evaluated by a neurologist or sleep specialist who can determine if it is right for your specific RLS symptoms.
Vibration therapy is an excellent tool because it carries virtually zero side effects. If you have a history of blood clots (DVT) in your legs, or have acute peripheral neuropathy, always double-check with a doctor before applying deep, consistent vibration to your calves.
For more information about treatments visit the "Restless Legs Syndrome" Wikipedia page.
Last reviewed 05/08/2026